Quinnova has made available its Atrapro brand with two products, Atrapro Antipruritic Hydrogel and Atrapro Dermal Spray with Preservatives. Each product formulation features patented Microcyn, providing steroid-free, non-cytotoxic, and non-irritating relief.

Atrapro Antipruritic Hydrogel is indicated to relieve the pain, burning and itching associated with various dermatoses, including atopic dermatitis and radiation dermatitis. In a two-week clinical study involving 17 patients with pruritic atopic dermatitis, most patients reported itch relief within three days of initiating treatment with the product. Atrapro Antipruritic Hydrogel is available in a 4oz tube.

Atrapro Dermal Spray with Preservatives is indicated for the management via debridement of wounds such as stage I-IV pressure ulcers, partial- and full-thickness wounds, diabetic foot ulcers, post-surgical wounds, first- and second-degree burns, and grafted and donor sites. Atrapro Dermal Spray with Preservatives assists in the physical removal of biofilm, eliminates wound odor, and features a preservative system that is gentle and non-irritating to compromised tissue. Atrapro Dermal Spray with Preservatives is available in an 8oz finger-pump bottle.

For more information, call (877) 660-6263 or visit www.quinnova.com.